Metabolic gene polymorphism frequencies in control populations

Cancer Epidemiology Biomarkers and Prevention

Volumn 10, Issue 12, 2001, Pages 1239-1248

  Garte, Seymour ^a,b   Gaspari, Laura ^b   Alexandrie, Anna Karin ^c   Rannug, Agneta ^c   Ingelman Sundberg, Magnus ^c   Persson, Irene ^c   Ambrosone, Christine ^d   Autrup, Herman ^e   Autrup, Judith L ^e   Baranova, Helena ^f   Bathum, Lise ^g   Boffetta, Paolo ^h   Breskvar, Katja ⁱ   Dolzan, Vita ⁱ   Brockmoller, Jurgen ^j   Cascorbi, Ingolf ^k   Clapper, Margie L ^l   Dresler, Carolyn M ^l   Coutelle, Christiane ^m   Daly, Ann ⁿ   Dell’Omo, Marco ^o   Fryer, Anthony ^p   Strange, Richard C ^p   Haugen, Aage ^q   Ryberg, David ^q   Hein, David W ^r   Hildesheim, Allan ^s   Hirvonen, Ari ^t   Hsieh, Ling Ling ^u   Kalina, Ivan ^v   Salagovic, Jan ^v   Kang, Daehee ^w   Kihara, Masahiro ^x   Noda, Kazumasa ^x   Kiyohara, Chikako ^y   Kremers, Pierre ^z   Roelandt, Liliane ^z   Lazarus, Philip ^aa   Le Marchand, Loéc ^ab   Lechner, Maria Celeste ^ac   Van Lieshout, Ester M M ^ad   Peters, Wilbert H M ^ad   London, Stephanie ^ae   Manni, Johannes J ^af   Maugard, Christine M ^ag   Morita, Shunji ^ah   Nazar Stewart, Valle ^ai   Oda, Yoshio ^aj   Parl, Fritz F ^ak   Pastorelli, Roberta ^al   Rebbeck, Timothy ^am   Risch, Angela ^an   Romkes, Marjorie ^ao   Schoket, Bernadette ^ap   Seidegard, Janeric ^aq   Shields, Peter G ^ar   Sim, Edith ^as   Sinnet, Daniel ^at   Sugimura, Haruhiko ^au   To Figueras, Jordi ^av   Vineis, Paolo ^aw   Yu, Mimi C ^ax   Taioli, Emanuela ^ay   more..

^a RUTGERS UNIVERSITY   (United States)

^b Genetics Research Institute   (Italy)

^c KAROLINSKA INSTITUTE   (Sweden)

^d NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^e AARHUS UNIVERSITY   (Denmark)

^f UNIVERSITÉ CLERMONT AUVERGNE   (France)

^g ODENSE UNIVERSITY HOSPITAL   (Denmark)

^h INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

ⁱ UNIVERSITY OF LJUBLJANA   (Slovenia)

^j CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^k UNIVERSITY OF GREIFSWALD   (Germany)

^l FOX CHASE CANCER CENTER   (United States)

^m UNIVERSITÉ DE BORDEAUX   (France)

ⁿ NEWCASTLE UNIVERSITY   (United Kingdom)

^o Instituto Medicina del Lavoro   (Italy)

^p KEELE UNIVERSITY   (United Kingdom)

^q NATIONAL INSTITUTE OF OCCUPATIONAL HEALTH   (Norway)

^r UNIVERSITY OF LOUISVILLE   (United States)

^s NATIONAL CANCER INSTITUTE   (United States)

^t FINNISH INSTITUTE OF OCCUPATIONAL HEALTH   (Finland)

^u CHANG GUNG UNIVERSITY   (Taiwan)

^v P J AFÁRIK UNIVERSITY   (Slovakia)

^w Seoul National University College of Medicine   (South Korea)

^x KYOTO UNIVERSITY SCHOOL OF PUBLIC HEALTH   (Japan)

^y KYUSHU UNIVERSITY   (Japan)

^z L'Univeisité de Liège Belgium   (Belgium)

^aa H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^ab UNIVERSITY OF HAWAII   (United States)

^ac UNIVERSITY OF LISBON   (Portugal)

^ad RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^ae NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^af MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^ag CENTRE RENÉ GAUDUCHEAU   (France)

^ah Yao Municipal Hospital   (Japan)

^ai OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^aj KANAZAWA UNIVERSITY   (Japan)

^ak VANDERBILT UNIVERSITY   (United States)

^al MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^am UNIVERSITY OF PENNSYLVANIA   (United States)

^an GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^ao UNIVERSITY OF PITTSBURGH   (United States)

^ap NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH   (Hungary)

^aq LUND UNIVERSITY   (Sweden)

^ar GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^as UNIVERSITY OF OXFORD   (United Kingdom)

^at UNIVERSITY OF MONTREAL   (Canada)

^au HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^av HOSPITAL CLÍNIC   (Spain)

^aw UNIVERSITY OF TURIN   (Italy)

^ax UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^ay FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450 1A1; CYTOCHROME P450 2D6; CYTOCHROME P450 2E1; GLUTATHIONE TRANSFERASE;

ALLELE; ARTICLE; ASIAN; CAUCASIAN; CYP1A1 GENE; CYP2D6 GENE; CYP2E1 GENE; ENVIRONMENTAL FACTOR; EPHX GENE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC HETEROGENEITY; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; GSTM1 GENE; GSTP GENE; GSTT1 GENE; HOSPITAL PATIENT; HUMAN; MAJOR CLINICAL STUDY; METABOLIC GENE; NAT2 GENE; NEGRO; POPULATION GENETICS; PRIORITY JOURNAL; RACE DIFFERENCE;

AFRICAN CONTINENTAL ANCESTRY GROUP; CYTOCHROME P-450 ENZYME SYSTEM; DATABASES, FACTUAL; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LINKAGE (GENETICS); NEOPLASMS; POLYMORPHISM, GENETIC;

EID: 0035660166     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (79)

1. Molecular genetics and epidemiology of the NAT1 and NAT2 acetylation polymorphisms
2. Arylamine N-acetyltransferase activity in man
3. Glutathione S-transferases - Biomarkers of cancer risk and chemopreventive response
4. Polymorphism in glutathione S-transferase loci as a risk factor for common cancers
5. Polymorphisms of xenobiotic-metabolizing enzymes and susceptibility to cancer
6. Genetic polymorphisms in human xenobiotica metabolizing enzymes as susceptibility factors in toxic response
7. Genetic polymorphism of CYP genes, alone or in combination, as a risk modifier of tobacco-related cancers
8. International collaborative study on genetic susceptibility to environmental carcinogens
9. The role of ethnicity in cancer susceptibility gene polymorphisms: The example of CYP1A1
10. Lung cancer risk in relation to genetic polymorphisms of microsomal epoxide hydrolase among African-Americans and Caucasians in Los Angeles County
11. Human glutathione S-transferase P1 polymorphisms: Relationship to lung tissue enzyme activity and population frequency distribution
12. Populations and genetic polymorphisms
13. Glutathione-S-transferase (GSTM1) genetic polymorphisms do not affect human breast cancer risk, regardless of dietary antioxidants
14. Breast cancer risk, meat consumption and N-acetyltransferase (NAT2) genetic polymorphisms
15. CYP2D6 ultrarapid metabolizer genotype as a potential modifier of smoking behaviour
16. Polymorphism in cytochrome P450 CYP2D6, CYP1A1, CYP2E1 and glutathione S-transferase, GSTM1, GSTM3, GSTT1 and susceptibility to tobacco-related cancers: Studies in upper aerodigestive tract cancers
17. CYP2D6 phenotype-genotype relationships in African-Americans and Caucasians in Los Angeles
18. L-myc, GST M1 genetic polymorphism and hepatocellular carcinoma risk among chronic hepatitis B carriers
19. Correlation between P450 CYP1A1 inducibility, MspI genotype and lung cancer incidence
20. The glutathione S-transferase μ polymorphism as a marker for susceptibility to lung carcinoma
21. Genotypic and phenotypic determination of polymorphic glutathione transferase T1 in a Swedish population
22. Genetics of CYP1A1: Coamplification of specific alleles by polymerase chain reaction and association with breast cancer
23. Slow N-acetylation genotype is a susceptibility factor in occupational and smoking related bladder cancer
24. GSTM1, smoking and lung cancer: A case-control study
25. Cytochrome P450 CYP2D6 gene polymorphism and lung cancer susceptibility in Caucasians
26. Associations of CYP1A1, GSTM1, and CYP2E1 polymorphisms with lung cancer suggest cell type specificities to tobacco carcinogens
27. Polymorphisms in NAT2, CYP2D6, CYP2C19 and GSTP1 and their association with prostate cancer
28. Glutathione S-transferases as risk factors in prostate cancer
29. Human acetylator genotype: Relationship to colorectal cancer incidence and arylamine N-acetyl-transferase expression in colon cytosol
30. Glutathione S-transferase M1 (GSTM1) and T1 (GSTT1) polymorphisms and lung cancer risk among Northwestern Mediterraneans
31. White blood cell DNA adducts, smoking, and NAT2 and GSTM1 genotypes in bladder cancer: A case-control study
32. Peculiarities of the GSTM1 0/0 genotype in French heavy smokers with various types of chronic bronchitis
33. Role of glutathione S-transferase GSTM1, GSTM3, GSTP1 and GSTT1 genotypes in modulating susceptibility to smoking-related lung cancer
34. Allele frequency of CYP2C19 in a Portuguese population
35. Comparison of GSTM polymorphisms and risk for oral cancer between African-Americans and Caucasians
36. Susceptibility to childhood acute lymphoblastic leukemia: Influence of CYP1A1, CYP2D6, GSTM1, and GSTT1 genetic polymorphisms
37. Genotypes for the cytochrome P450 enzymes CYP2D6 and CYP2C19 in human longevity. Role of CYP2D6 and CYP2C19 in longevity
38. Urinary total isothiocyanate (ITC) in a population-based sample of middle-aged and older Chinese in Singapore: Relationship with dietary total ITC and glutathione S-transferase M1/T1/P1 genotypes
39. Allelotype influence at glutathione S-transferase M1 locus on breast cancer susceptibility
40. The relationship between aryl hydrocarbon hydroxylase and polymorphisms of the CYP1A1 gene
41. Breast cancer and CYPIA1, GSTM1, and GSTT1 polymorphisms: Evidence of a lack of association in Caucasians and African Americans
42. Genetic polymorphism of glutathione S-transferases M1 and T1 as a risk factor in lung and bladder cancers
43. CYP2E1 genetic polymorphisms and risk of nasopharyngeal carcinoma in Taiwan
44. Laryngeal and oropharyngeal cancer, and alcohol dehydrogenase 3 and glutathione S-transferase M1 polymorphisms
45. Association of low CYP3A activity with p53 mutation and CYP2D6 activity with Rb mutation in human bladder cancer
46. Combined analysis of inherited polymorphisms in arylamine N-acetyltransferase 2, glutathione S-transferases M1 and T1, microsomal epoxide hydrolase, and cytochrome P450 enzymes as modulators of bladder cancer risk
47. Human CYP2D6 gene polymorphism in Slovene cancer patients and healthy controls
48. Cytochrome P4501A1 gene polymorphism and homozygous deletion of the glutathione S-transferase M1 gene in urothelial cancer patients
49. Risk of smoking for squamous and small cell carcinomas of the lung modulated by combinations of CYP1A1 and GSTM1 gene polymorphisms in a Japanese population
50. Relation between the occurrence of K-ras gene point mutations and genotypes of polymorphic N-acetyltransferase in human colorectal carcinomas
51. Lung cancer, race, and a CYP1A1 genetic polymorphism
52. Association of Ile462Val (exon 7) polymorphism of cytochrome P450 IA1 with lung cancer in the Asian population: Further evidence from a case-control study in Okinawa
53. The GSTM1 genetic polymorphism in healthy Saudi Arabians and Filipinos, and Saudi Arabians with coronary atherosclerosis
54. A C4887A polymorphism in exon 7 of human CYP1A1: Population frequency, mutation linkages, and impact on lung cancer susceptibility
55. Association of arylamine N-acetyltransferases NAT1 and NAT2 genotypes to laryngeal cancer risk
56. Lung cancer risk in nonsmokers and GSTM1 and GSTT1 genetic polymorphism
57. Human CYP1A1 (cytochrome P(1)450) gene: Lack of association between the Msp 1 restriction fragment length polymorphism and incidence of lung cancer in a Norwegian population
58. Genotypes of glutathione transferase M1 and P1 and their significance for lung DNA adduct levels and cancer risk
59. Polymorphic expression of the glutathione S-transferase P1 gene and its susceptibility to Barrett’s esophagus and esophageal carcinoma
60. Smoking-associated bulky DNA adducts in bronchial tissue related to CYP1A1 MspI and GSTM1 genotypes in lung patients
61. A specific African American CYP1A1 polymorphism is associated with adenocarcinoma of the lung
62. Enhanced risk of lung and prostate adenocarcinoma in African-American smokers carrying a novel cyp1A1 gene polymorphism
63. Lung cancer risk and CYP1A1 genotype in African Americans
64. Genetic polymorphism of xenobiotic metabolizing enzymes among Chinese lung cancer patients
65. CYP1A1, CYP2E1 and GSTM1 polymorphisms are not associated with susceptibility to squamous-cell carcinoma of the esophagus
66. Glutathione S-transferase M1 and T1 and cytochrome P4501A1 polymorphisms in relation to the risk for benign and malignant head and neck lesions
67. Metabolic gene allele nomenclature
68. Human cytochrome P-450 (CYP) genes: A web page for the nomenclature of alelles
69. Nomenclature for N-acetyltransferases
70. Update on consensus arylamine N-acetyltransferase gene nomenclature
71. Human cytochrome P450 (CYP) genes: Recommendations for the nomenclature of alleles
72. Suggestions for the nomenclature of human alleles: Relevance to ecogenetics, pharmacogenetics and molecular epidemiology
73. Population stratification in epidemiologic studies of common genetic variants and cancer: Quantification of bias
74. Distribution of metabolic genes polymorphisms in healthy centenarians
75. Placental expression of arylamine N-acetyltransferases: Evidence for linkage disequilibrium between NAT1 * 10 and NAT2*4 alleles of the two human arylamine N-acetyltransferase loci NAT1 and NAT2
76. Presentation with multiple cutaneous basal cell carcinomas: Association of glutathione S-transferase and cytochrome P450 genotypes with clinical phenotype
77. Relevance of N-acetyltransferases 1 and 2 (NAT1, NAT2) genetic polymorphisms in non-small lung cancer